Entradas

Mostrando entradas de febrero, 2021

A Consensus Approach to the Primary Prevention of Food Allergy Through Nutrition: Guidance from the American Academy of Allergy, Asthma, and Immunology; American College of Allergy, Asthma, and Immunology; and the Canadian Society for Allergy and Clinical Immunology. Miércoles 3 de febrero

A Consensus Approach to the Primary Prevention of Food Allergy Through Nutrition: Guidance from the American Academy of Allergy, Asthma, and Immunology; American College of Allergy, Asthma, and Immunology; and the Canadian Society for Allergy and Clinical Immunology Authors:  David M Fleischer  1 , Edmond S Chan  2 , Carina Venter  1 , Jonathan M Spergel  3 , Elissa M Abrams  4 , David Stukus  5 , Marion Groetch  6 , Marcus Shaker  7 , Matthew Greenhawt  8 Abstract Recently published data from high-impact randomized controlled trials indicate the strong potential of strategies to prevent the development of food allergy in high-risk individuals, but guidance in the United States at present is limited to a policy for only the prevention of peanut allergy, despite other data being available and several other countries advocating early egg and peanut introduction. Eczema is considered the highest risk factor for developing IgE-mediated food allergy, but children without risk factors still

US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema. Martes 2 de febrero

US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema Authors:  Paula J Busse  1 , Sandra C Christiansen  2 , Marc A Riedl  2 , Aleena Banerji  3 , Jonathan A Bernstein  4 , Anthony J Castaldo  5 , Timothy Craig  6 , Mark Davis-Lorton  7 , Michael M Frank  8 , H Henry Li  9 , William R Lumry  10 , Bruce L Zuraw  11 Abstract Scientific and clinical progress together with the development of effective novel therapeutic options has engendered multiple important changes in the diagnosis and management of hereditary angioedema (HAE). We now update and extend the 2013 United States Hereditary Angioedema Association Medical Advisory Board guidelines for the treatment and management of HAE. The guidelines are based on a comprehensive literature review with recommendations indicating both the strength of our recommendation and the quality of the underlying evidence. Guidelines are provided regarding the classification, diagnosis, on-demand treatment, prophyla

Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. Lunes 1 de febrero

 Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs Authors:  Ana Dioun Broyles  1 , Aleena Banerji  2 , Sara Barmettler  2 , Catherine M Biggs  3 , Kimberly Blumenthal  2 , Patrick J Brennan  4 , Rebecca G Breslow  5 , Knut Brockow  6 , Kathleen M Buchheit  4 , Katherine N Cahill  7 , Josefina Cernadas  8 , Anca Mirela Chiriac  9 , Elena Crestani  1 , Pascal Demoly  9 , Pascale Dewachter  10 , Meredith Dilley  1 , Jocelyn R Farmer  2 , Dinah Foer  4 , Ari J Fried  1 , Sarah L Garon  11 , Matthew P Giannetti  4 , David L Hepner  12 , David I Hong  4 , Joyce T Hsu  4 , Parul H Kothari  4 , Timothy Kyin  13 , Timothy Lax  14 , Min Jung Lee  15 , Kathleen Lee-Sarwar  16 , Anne Liu  17 , Stephanie Logsdon  18 , Margee Louisias  4 , Andrew MacGinnitie  1 , Michelle Maciag  1 , Samantha Minnicozzi  19 , Allison E Norton  20 , Iris M Otani  21 , Miguel Park  22 , Sarita Patil  2 , Elizabeth J Phillips  23 , Matthieu Picard  24 , Craig D Platt  25 , R